Therapeutic Role Many breast cancer cells depend on estrogen to support their growth. Exemestane permanently inactivates the aromatase enzyme responsible for producing estrogen after menopause. This lowers estrogen availability and may slow or suppress the growth of hormone-sensitive cancer cells. Safety Advice Medical supervision: Exemestane should be taken only according to the prescribing oncologist’s directions. Patients should not change the dose, discontinue therapy or restart treatment without medical advice. Pregnancy: Exemestane can harm an unborn baby and is not intended for use during pregnancy. Patients who may become pregnant should discuss effective contraception and pregnancy testing requirements with their doctor. Breastfeeding: Breastfeeding is generally not recommended during treatment and for the period specified by the treating physician after the final dose. Bone health: Lower estrogen levels can reduce bone-mineral density and increase the risk of osteoporosis or fractures. Doctors may evaluate bone health before and during long-term therapy. Liver and kidney conditions: Clinical monitoring may be required even when a routine dose adjustment is not prescribed. Vitamin D assessment: Patients with low vitamin D levels may require assessment or supplementation based on their clinician’s advice. Storage and Handling: Store the tablets at the temperature stated on the approved product label. Keep them in their original, tightly closed packaging. Keep it away from children and unauthorized persons. Do not use tablets that are expired, broken, contaminated or stored incorrectly. FAQs 1. What are Exemestane Tablets 25mg prescribed for? They are prescribed for selected postmenopausal women with estrogen-sensitive early or advanced breast cancer, particularly within treatment plans involving previous tamoxifen therapy. 2. Is Exemestane a chemotherapy medicine? Exemestane is classified as endocrine or hormonal therapy rather than conventional cytotoxic chemotherapy. It reduces estrogen production by permanently blocking the aromatase enzyme. 3. How should Exemestane Tablets be taken? The approved prescribing information recommends one 25mg tablet once daily after a meal, but patients must follow the exact instructions given by their oncology specialist. 4. Can Exemestane affect bone strength? Yes. Long-term estrogen reduction may decrease bone-mineral density, so the healthcare provider may recommend bone-health monitoring and preventive measures. 5. Can importers order Exemestane Tablets in bulk? Licensed importers, hospitals and authorized distributors may request commercial quantities, subject to product availability, prescription-drug regulations and the importing country’s approvals. Description Source Exemestane Tablets 25mg from an Indian pharmaceutical exporter for licensed buyers in Jamaica and Indonesia. Bulk supply and export documentation available. 🌍 Ernest Oncology | Global Oncology Medicine Export Solutions [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Export • Distribution • Procurement 📲 WhatsApp: +91 9405476170 https://wa.me/message/V2MEXZ6ZAYY5B1 #ExemestaneTablets25mg #ExemestaneSupplier #BreastCancerMedicine #HormonalCancerTherapy #AromataseInhibitor #OncologyMedicineExporter #PharmaceuticalExporterIndia #KingstonPharmaSupply #JamaicaHealthcare #JakartaPharmaImporter #IndonesiaOncology #BulkMedicineSupplier #HospitalPharmaceuticalSupply #CancerCareProcurement #InternationalPharmaTrade #LicensedMedicineImporter #OncologyTabletDistributor #GlobalHealthcareSupply #IndianPharmaExporter #ErnestOncology
Washington, USA
08048034998
+919405476170
Chat with us
Chat with us